BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25664503)

  • 1. Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.
    Bjarnason A; Asgeirsson H; Baldursson O; Kristinsson KG; Gottfredsson M
    Infect Dis (Lond); 2015 Mar; 47(3):130-6. PubMed ID: 25664503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.
    Umeki K; Tokimatsu I; Yasuda C; Iwata A; Yoshioka D; Ishii H; Shirai R; Kishi K; Hiramatsu K; Matsumoto B; Kadota J
    Respirology; 2011 Jul; 16(5):856-61. PubMed ID: 21545370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
    Falcone M; Venditti M; Shindo Y; Kollef MH
    Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
    Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
    Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
    Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
    J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].
    Taşbakan MS; Bacakoğlu F; Başoğlu OK; Gürgün A; Başarik B; Citim Tuncel S; Sayiner A
    Tuberk Toraks; 2011; 59(4):348-54. PubMed ID: 22233304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
    Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
    Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
    Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
    J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
    Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals.
    Hoo Lee J; Hyung Kim Y
    Braz J Infect Dis; 2012; 16(4):321-8. PubMed ID: 22846118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
    Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
    Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of patients with hemodialysis-associated pneumonia compared to patients with non-hemodialysis community-onset pneumonia.
    Lee JH; Moon JC
    Respir Med; 2016 Feb; 111():84-90. PubMed ID: 26777263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
    Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital.
    Park HK; Song JU; Um SW; Koh WJ; Suh GY; Chung MP; Kim H; Kwon OJ; Jeon K
    Respir Med; 2010 Nov; 104(11):1729-35. PubMed ID: 20605087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.